A citation-based method for searching scientific literature

Mieke R Van Bockstal, Marie C Agahozo, Linetta B Koppert, Carolien H M van Deurzen. Int J Cancer 2020
Times Cited: 11

List of co-cited articles
67 articles co-cited >1

Times Cited
  Times     Co-cited

Ductal carcinoma in situ: a proposal for a new classification.
R Holland, J L Peterse, R R Millis, V Eusebi, D Faverly, M J van de Vijver, B Zafrani. Semin Diagn Pathol 1994

Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: Critical review.
M Toss, I Miligy, A M Thompson, H Khout, A R Green, I O Ellis, E A Rakha. Breast 2017

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial.
S E Pinder, C Duggan, I O Ellis, J Cuzick, J F Forbes, H Bishop, I S Fentiman, W D George. Br J Cancer 2010

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands.
Carmen van Dooijeweert, Paul J van Diest, Stefan M Willems, Chantal C H J Kuijpers, Lucy I H Overbeek, Ivette A G Deckers. Breast Cancer Res Treat 2019

Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010

Significant inter- and intra-laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands.
Carmen van Dooijeweert, Paul J van Diest, Stefan M Willems, Chantal C H J Kuijpers, Elsken van der Wall, Lucy I H Overbeek, Ivette A G Deckers. Int J Cancer 2020

Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Mieke Van Bockstal, Kathleen Lambein, Ann Smeets, Laurence Slembrouck, Patrick Neven, Ines Nevelsteen, Caroline Weltens, Erik Van Limbergen, Marie-Rose Christiaens, Chantal Van Ongeval,[...]. Eur J Surg Oncol 2019

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010

Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Mieke Van Bockstal, Marcella Baldewijns, Cécile Colpaert, Hélène Dano, Giuseppe Floris, Christine Galant, Kathleen Lambein, Dieter Peeters, Sofie Van Renterghem, Anne-Sophie Van Rompuy,[...]. Histopathology 2018

Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.
A G Douglas-Jones, J M Morgan, M A Appleton, R L Attanoos, A Caslin, C S Champ, M Cotter, N S Dallimore, A Dawson, R W Fortt,[...]. J Clin Pathol 2000

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010

Histopathological grading of breast ductal carcinoma in situ: validation of a web-based survey through intra-observer reproducibility analysis.
Fernando Schuh, Jorge Villanova Biazús, Erika Resetkova, Camila Zanella Benfica, Alessandra de Freitas Ventura, Diego Uchoa, Márcia Graudenz, Maria Isabel Albano Edelweiss. Diagn Pathol 2015

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015

Reproducibility of three classification systems of ductal carcinoma in situ of the breast using a web-based survey.
Fernando Schuh, Jorge Villanova Biazús, Erika Resetkova, Camila Zanella Benfica, Maria Isabel Albano Edelweiss. Pathol Res Pract 2010

Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Hélène Dano, Serdar Altinay, Laurent Arnould, Noella Bletard, Cecile Colpaert, Franceska Dedeurwaerdere, Benjamin Dessauvagie, Valérie Duwel, Giuseppe Floris, Stephen Fox,[...]. Mod Pathol 2020

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.
Wenjing Zhou, Christine Johansson, Karin Jirström, Anita Ringberg, Carl Blomqvist, Rose-Marie Amini, Marie-Louise Fjallskog, Fredrik Wärnberg. Int J Breast Cancer 2013

Whole slide imaging equivalency and efficiency study: experience at a large academic center.
Matthew G Hanna, Victor E Reuter, Meera R Hameed, Lee K Tan, Sarah Chiang, Carlie Sigel, Travis Hollmann, Dilip Giri, Jennifer Samboy, Carlos Moradel,[...]. Mod Pathol 2019

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial.
Daniel Rea, Adele Francis, Matthew Wallis, Jeremy Thomas, John Bartlett, Sarah Bowden, David Dodwell, Lesley Fallowfield, Claire Gaunt, Andrew Hanby,[...]. Ann Surg Oncol 2017

The Vienna classification of gastrointestinal epithelial neoplasia.
R J Schlemper, R H Riddell, Y Kato, F Borchard, H S Cooper, S M Dawsey, M F Dixon, C M Fenoglio-Preiser, J F Fléjou, K Geboes,[...]. Gut 2000

The requirements of a specialist Breast Centre.
A R M Wilson, L Marotti, S Bianchi, L Biganzoli, S Claassen, T Decker, A Frigerio, A Goldhirsch, E G Gustafsson, R E Mansel,[...]. Eur J Cancer 2013

Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
N Sneige, M D Lagios, R Schwarting, W Colburn, E Atkinson, D Weber, A Sahin, B Kemp, A Hoque, S Risin,[...]. Hum Pathol 1999

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Maria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, Gert van den Eynden, Nils Ternes, Frederique Penault-Llorca, Giancarlo Pruneri, Timothy M D'Alfonso, Sandra Demaria, Carlos Castaneda,[...]. Semin Cancer Biol 2018

Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
J P Sloane, I Amendoeira, N Apostolikas, J P Bellocq, S Bianchi, W Boecker, G Bussolati, D Coleman, C E Connolly, P Dervan,[...]. Hum Pathol 1998

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.
Teresa M Darragh, Terence J Colgan, J Thomas Cox, Debra S Heller, Michael R Henry, Ronald D Luff, Timothy McCalmont, Ritu Nayar, Joel M Palefsky, Mark H Stoler,[...]. Arch Pathol Lab Med 2012

Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.
S J Schnitt, J L Connolly, F A Tavassoli, R E Fechner, R L Kempson, R Gelman, D L Page. Am J Surg Pathol 1992

Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006

Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.
Emad A Rakha, Rachel L Bennett, Derek Coleman, Sarah E Pinder, Ian O Ellis. J Clin Pathol 2017

Current approach and future perspective for ductal carcinoma in situ of the breast.
Chizuko Kanbayashi, Hiroji Iwata. Jpn J Clin Oncol 2017

Molecular Evaluation of Breast Ductal Carcinoma in Situ with Oncotype DX DCIS.
Sharon Nofech-Mozes, Wedad Hanna, Eileen Rakovitch. Am J Pathol 2019

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
Susan C Lester, Shikha Bose, Yunn-Yi Chen, James L Connolly, Monica E de Baca, Patrick L Fitzgibbons, Daniel F Hayes, Celina Kleer, Frances P O'Malley, David L Page,[...]. Arch Pathol Lab Med 2009

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype.
M Lazzeroni, A Guerrieri-Gonzaga, E Botteri, M C Leonardi, N Rotmensz, D Serrano, C Varricchio, D Disalvatore, A Del Castillo, F Bassi,[...]. Br J Cancer 2013

Diagnostic concordance among pathologists interpreting breast biopsy specimens.
Joann G Elmore, Gary M Longton, Patricia A Carney, Berta M Geller, Tracy Onega, Anna N A Tosteson, Heidi D Nelson, Margaret S Pepe, Kimberly H Allison, Stuart J Schnitt,[...]. JAMA 2015

Ductal carcinoma in situ - update on risk assessment and management.
Jia-Min B Pang, Kylie L Gorringe, Stephen B Fox. Histopathology 2016

Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995

Impact of breast cancer grade discordance on prediction of outcome.
Emad A Rakha, Mohammed A Aleskandarany, Michael S Toss, Nigel P Mongan, Maysa E ElSayed, Andrew R Green, Ian O Ellis, Les W Dalton. Histopathology 2018

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
Andrea DeCensi, Matteo Puntoni, Aliana Guerrieri-Gonzaga, Silvia Caviglia, Franca Avino, Laura Cortesi, Cristiana Taverniti, Maria Grazia Pacquola, Fabio Falcini, Marcella Gulisano,[...]. J Clin Oncol 2019

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
G Curigliano, H J Burstein, E P Winer, M Gnant, P Dubsky, S Loibl, M Colleoni, M M Regan, M Piccart-Gebhart, H-J Senn,[...]. Ann Oncol 2017

Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Emma J Groen, Lotte E Elshof, Lindy L Visser, Emiel J Th Rutgers, Hillegonda A O Winter-Warnars, Esther H Lips, Jelle Wesseling. Breast 2017

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015

Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.
C W Elston, J P Sloane, I Amendoeira, N Apostolikas, J P Bellocq, S Bianchi, W Boecker, G Bussolati, D Coleman, C E Connolly,[...]. Eur J Cancer 2000

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019

Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
Benjamin D Smith, Jennifer R Bellon, Rachel Blitzblau, Gary Freedman, Bruce Haffty, Carol Hahn, Francine Halberg, Karen Hoffman, Kathleen Horst, Jean Moran,[...]. Pract Radiat Oncol 2018

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.